A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
From funding tailwinds to accelerating technology adoption, the Healthcare IT sector is entering a pivotal phase. In this video, Allen Klee of Maxim Group examines where the industry stands in the cycle, how federal initiatives and emerging technologies like AI are...
Niagen Bioscience, Inc. (NASDAQ: NAGE), formerly ChromaDex Corp., is the global leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. This company webcast was recorded during the Lytham Partners 2026 Investor Healthcare Summit.
Biofrontera Inc. (Nasdaq: BFRI) is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. This company webcast was...
Jaguar Health, Inc. (Nasdaq: JAGX) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically...
Reviva Pharma (Nasdaq: RVPH) is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families. This company...
PolyPid Ltd. (Nasdaq: PYPD) is a late-stage biopharma company aiming to improve surgical outcomes. This company webcast was recorded during the Lytham Partners 2026 Investor Healthcare Summit.
NeurAxis, Inc., (NYSE American: NRXS) is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults. This company webcast was recorded during the Lytham Partners 2026 Investor Healthcare...